---
title: "Europe/US Sessions"
subtitle: "8 thematic sessions with 30+ presentations"
toc: true
---

## Session 1: Practical AI & Industry Adoption

### Practical AI for Data Science

**Simon Couch** (Posit)

Focus on unglamorous but practical AI uses in pharma: structured data extraction, tool calling, and coding assistance. Using `{ellmer}` for secure, on-premise deployments that protect proprietary information.

**Key Points:**

-   Most AI discourse focuses on flashy applications, but practical uses dominate daily work
-   Secure deployments enable AI even with confidential data
-   Three core use cases: extraction, tool calling, coding

**Resources:** [github.com/simonpcouch](https://github.com/simonpcouch)

------------------------------------------------------------------------

## Session 2: Data Engineering & Training

### duckplyr: Analyze Large Data with DuckDB

**Kirill Muller** (Cynkra)

Stable release (v1.1.2) of `{duckplyr}` brings DuckDB's performance to dplyr syntax. Handle larger-than-memory data from disk or cloud with familiar tidyverse semantics.

**Key Features:**

-   Speed up existing dplyr code
-   Analyze Parquet/CSV directly
-   Access DuckDB functionality
-   Maintain R/tidyverse compatibility

### Beyond Training: Teaching R Adoption at GSK

**Alanah Jonas** (GSK)

GSK's evolution from basic R courses to **Rburst** - a comprehensive support model embedding R into daily workflows across Biostatistics.

**Evolution:**

1.  Two core courses in bookdown
2.  Self-certification and Resource Hub
3.  AccelerateR for early adopters
4.  Rburst for cross-functional integration

### Validating Shiny Apps in Regulated Environments

**Pedro Silva** (Jumping Rivers)

Practical validation approaches for Shiny in clinical/healthcare settings using **Litmusverse** suite.

**Key Topics:**

-   Traceability and documentation
-   Risk-based validation
-   Versioning strategies
-   Code quality assessment tools

### Beyond {gtsummary}: The {crane} Package

**Daniel Sjoberg, Davide Garolini** (Genentech)

`{crane}` extends `{gtsummary}` for pharmaceutical reporting with ARD-based QC and LLM summarization.

**Advantages:**

1.  Instant upgrades when `{crane}` is loaded
2.  ARD-based QC is straightforward
3.  LLMs summarize results for medical writers
4.  Adapt for your needs or build your own

**Resources:** [danieldsjoberg.com/RinPharma-crane-2025](https://www.danieldsjoberg.com/RinPharma-crane-2025/)

------------------------------------------------------------------------

## Session 3: Advanced AI Systems

### {llumen}: Agentic LLM Framework for Biomedical Documents

**Sven-Eric Schelhorn** (Merck KGaA)

Internal package at Merck enabling pharmaceutical researchers to work with biomedical documents, databases, and foundation models using LLMs as orchestrators.

**Capabilities:**

-   Multi-source LLMs (Azure, OpenAI, local)
-   Vector DB with office document support (Word, Excel, PDF)
-   RAG with PaperQA2 approach
-   Database querying (SQL, Cypher, GraphQL)
-   Foundation models (e.g., TxGemma)
-   Histopathology image analysis

**Use Cases:**

1.  Extract results from clinical trial documents
2.  Query tabular databases and knowledge graphs
3.  Biological foundation models integration
4.  Automated literature review
5.  Histopathology analysis
6.  Drug discovery support

**Resources:** [Drive presentation](https://drive.google.com/file/d/1g0_O_wSoeBHzeXl6DF3-NIY7gT2Bk62_/view)

### Build Model Context Protocol Servers in R

**John Coene** (Opifex)

`{mcpr}` provides R implementation of Model Context Protocol (MCP) - standardized JSON-RPC interface for AI models.

**Features:**

-   Schema-based tool definitions
-   Multi-modal responses
-   Integration with Claude Code, Cursor, VS Code
-   Server and client functionality

**Impact:** Democratizes AI-R integration with standards-based approach.

------------------------------------------------------------------------

## Session 4: Automation & Innovation

### Mosaic: ARS-Driven Automation of Standard TFLs

**Conor Moloney** (Novartis)

CDISC Analysis Results Standard (ARS) coupled with open-source stack for automated TFL generation.

**Architecture:**

1.  YAML captures ARD requirements (ARS-aligned)
2.  LinkML validation
3.  Python storage via SQL Alchemy
4.  R derives ARD (language-agnostic rules)
5.  React UI for customization and export

**Benefits:**

-   Replaces ad-hoc programming
-   Standards-based pipeline
-   Accelerates delivery
-   Safeguards traceability

### Integrating Collaborative Programming with Traceability

**Jennifer Dusendang, Sundeep Bath** (Graticule Inc)

Adapting DevOps best practices for epidemiological studies and RWD projects.

**Implementation:**

-   Parameterized pipelines in Docker containers
-   CI/CD for automatic reanalysis
-   Code review with validated outputs
-   Automated traceability and audit trails

**Tools:** Git, GitHub Actions, SQL, Python, R, Docker, AWS S3

**Resources:** [PharmaSUG 2025 Paper](https://www.lexjansen.com/pharmasug/2025/OS/PharmaSUG-2025-OS-111.pdf)

------------------------------------------------------------------------

## Session 5: Machine Learning & AI Tools

### TabPFN: Deep Learning for Tabular Data

**Max Kuhn** (Posit)

Version 2 of TabPFN offers Bayesian-like approach for tabular data with significant advantages.

**Key Points:**

-   Trained on simulated tabular datasets
-   Fast inference (no training needed)
-   Emulates Bayesian posterior
-   Notable trade-offs to consider

**Resources:** [topepo.github.io/2025-r-pharma](https://topepo.github.io/2025-r-pharma/#/title-slide)

### The LLM Lounge: Live Coding with Databot

**Joe Cheng, Eric Nantz**

Interactive demonstration of **Databot** for exploratory data analysis.

**Topics:**

-   Databot origin story
-   AI trends in life sciences
-   Guiding principles for AI tools
-   Audience Q&A format

**Resources:** [github.com/posit-dev/querychat](https://github.com/posit-dev/querychat)

### LLM-Powered {gtsummary}: QC-Ready Tables

**Davide Garolini** (Roche/NEST)

Workflow fusing `{gtsummary}`, `{cards}` validation, and offline LLM helper.

**Process:**

1.  Create table with `{gtsummary}`
2.  Validate with `{cards}`
3.  LLM explains steps and results
4.  Generate descriptive log
5.  Rerun with real data unchanged

**Benefits:** Submission-ready tables in minutes with enhanced clarity.

### Post-Approval Drug Exposure Estimation

**Feifei Yang, Yu Zhang** (AstraZeneca)

R Shiny app automating post-marketing exposure calculations.

**Results:**

-   Report generation: 1 week â†’ 1 day
-   Built-in QC functions
-   Trend visualization
-   Team accessibility without training

### Implementing End-to-End NCA Software

**Gerardo Rodriguez, Jana Spinner** (Lucid Analytics)

**aNCA** - open-source Non-Compartmental Analysis app within Pharmaverse.

**Features:**

-   Interactive plots for exploration
-   Half-life customization
-   TLGs and report generation
-   100% testing coverage
-   Uses PKNCA (200+ PK parameters)
-   Industry-standard validation (Â±0.1%)

**Resources:** [github.com/pharmaverse/aNCA](https://github.com/pharmaverse/aNCA)

### Integrating LLM for Clinical Data Review

**Zhen Wu, Peng Zhang** (CIMS Global)

`{DataChat}` - conversational interface for clinical data with privacy and validity emphasis.

**Technologies:** `{ellmer}`, `{shinychat}`, `{ragnar}`, RAG capabilities

### R We There Yet? {admiral}'s Journey to Stability

**Edoardo Mancini** (Roche)

Discussion on transitioning mature packages from active development to maintenance.

**Questions Addressed:**

-   Sustaining team momentum at stability
-   New priorities post-feature completeness
-   Lessons from `{admiral}` evolution

------------------------------------------------------------------------

## Session 6: Enterprise Transformation

### GSK's Journey to Clinical Study Reporting Using Open Source

**Sam Warden, Tim Colman** (GSK)

Chronicles GSK's transformation from SAS-dominated era to open-source innovation.

**Key Milestones:**

-   FDA clarification on software neutrality
-   Rise of R and open-source platforms
-   GSK's 50%+ open-source code commitment
-   COVID-19 acceleration

**Challenges:**

-   Technical validation
-   Regulatory uncertainty
-   Cultural resistance
-   Governance and training needs

**Success Factors:** Growth mindset, adaptability, collaborative vision

------------------------------------------------------------------------

## Session 7: AI Integration Case Studies

### Leveraging ellmer and GPT in Shiny for Trials

**Xing Chen, Xiaolin Chang** (Moderna)

AI-enhanced Shiny app for CMI data across mRNA infectious disease programs.

**Features:**

-   Natural language queries â†’ R operations
-   Interactive data exploration
-   Customizable visualizations
-   No manual coding required

**Results:**

-   Faster insight extraction
-   Reduced ad-hoc programming
-   Enhanced cross-functional collaboration

### autoslideR: Streamlining Slide Deck Generation

**Yolanda Zhou, Joe Zhu** (Roche)

R package automating slide decks for clinical reporting events.

**Benefits:**

-   0.5-4 days saved per deck
-   Customized layout from templates
-   Placeholder slides for rapid prep
-   Multiple event types supported

**Resources:** [pharmaverse.github.io/examples/digit_files/autoslider.html](https://pharmaverse.github.io/examples/digit_files/autoslider.html)

### Putting the 'R' in RWD

**Sachin Heerah, Darren Jeng** (Pfizer)

Pfizer RWD team's R package and tools for programmers with varying backgrounds.

**Tools:**

-   Custom R package for database queries
-   Dual R/SAS syntax support
-   Shiny apps for workflow support
-   Code snippets in RStudio
-   Quarto website for documentation

### Generating Synthetic Data with synthpop

**Sophie Furlow** (Abbott Diagnostics)

Introduction to synthetic data generation for pharma and diagnostics.

**Topics:**

-   Synthetic vs simulated vs resampled data
-   Healthcare applications - `{synthpop}` machine learning algorithms
-   Quality evaluation features
-   Generation caveats

------------------------------------------------------------------------

## Session 8: Innovation & Advanced Methods

### GenAI in Production

**Devin Pastoor** (A2-AI)

Moving beyond prototypes to production AI applications in GxP contexts.

**Topics:**

-   Testing approaches for GenAI
-   Validation strategies
-   Handling user interaction flexibility
-   Release and maintenance

### Building the Ultimate R AI Assistant

**Pawel Rucki** (Roche)

Multi-agent R co-pilot with LangGraph framework.

**Architecture:**

-   Each R package gets its own AI agent
-   Network of specialized agents
-   Context-aware code generation
-   Integration with cursor via MCP

**Features:** Write, debug, and explain complex R code for clinical trials

### The Dependency Whisperer: AI for Impact Analysis

**Ming Yan, Vina Ro** (Eli Lilly)

AI-powered tool for identifying dependencies in clinical programming.

**Problem:** Traditional tools can't distinguish active code from comments or identify indirect dependencies.

**Solution:**

-   Parses SDTM, ADaM, TFL specs/programs
-   Learns dependency structure
-   Generates graphical impact reports
-   Ensures accurate refreshes

### BayesERtools: Bayesian Exposure-Response Analysis

**Kenta Yoshida** (Genentech)

New R package for Bayesian ER analysis with user-friendly interface.

**Features:**

-   Linear and Emax models
-   Continuous and binary endpoints
-   Based on Stan ecosystem
-   Comprehensive online book (BayesERbook)

**Resources:** [genentech.github.io/BayesERtools](https://genentech.github.io/BayesERtools/)

### Adapting to Regulatory Guidance

**Alex Przybylski** (Novartis)

FDA 2023 guidance on covariate adjustment and R-enabled submissions.

**Case Study:**

-   Strategic response to FDA feedback
-   Lightweight R solutions (`{beeca}`)
-   ASA-BIOP collaboration (`{RobinCar2}`)
-   Benefits of open-source community

### R Library Validation using ATDD

**Brian Repko** (ex-Novartis)

Acceptance-Test Driven Development for R package libraries.

**Approach:**

-   Tests written in Quarto markdown
-   "Given-when-then" format
-   Regex-matched against annotated functions
-   Can drive Shiny apps with `{chromote}`

**Benefits:** Plain-language tests shareable with regulators

------------------------------------------------------------------------

## ðŸ”‘ Key Themes Across Sessions

### 1. AI Integration

-   Practical, secure implementations
-   Agentic systems and MCP
-   Privacy-preserving approaches
-   Production-ready validation

### 2. Open Source Adoption

-   GSK leading with 50%+ R code
-   Industry-wide shift from SAS
-   Collaborative development (pharmaverse)
-   FDA acceptance growing

### 3. Automation & Efficiency

-   ARS-driven TFL generation
-   Automated slide decks
-   One-day turnaround for reports
-   CI/CD for clinical workflows

### 4. Validation & Compliance

-   GxP-ready AI applications
-   Risk-based validation approaches
-   Shared validation repositories
-   ATDD for package libraries

### 5. Advanced Analytics

-   Bayesian methods with Stan
-   Machine learning (TabPFN)
-   Synthetic data generation
-   High-performance computing

------------------------------------------------------------------------

*Europe/US Sessions from R/Pharma 2025 Conference \| Last updated: November 2025*